B cell lymphoma 2 (BCL-2; BCL2); cyclin dependent kinase 4 (CDK4); cyclin dependent kinase inhibitor 2A (CDKN2A; INK4a; ARF; p16INK4a); CDKN2B (INK4B; MTS2); retinoblastoma 1 (RB1) BriefCommunication Pages: 788 - 788
CTLA-4 (CD152); signal transducer and activator of transcription 3 (STAT3) BriefCommunication Pages: 790 - 790
Bromodomain containing 4 (BRD4); Wolf-Hirschhorn syndrome candidate 1-like 1 (WHSC1L1; NSD3); NUT midline carcinoma 1 (NUTM1; NUT; C15orf55) BriefCommunication Pages: 792 - 792
Phosphoinositide 3-kinase (PI3K); poly(ADP-ribose) polymerase (PARP) BriefCommunication Pages: 794 - 794
Family with sequence similarity 132 b (FAM132b; erythroferrone; myonectin) BriefCommunication Pages: 797 - 797
Mycobacterium tuberculosis decaprenylphosphoryl-β-D-ribose 2-oxidase (dprE1) BriefCommunication Pages: 798 - 798
v-abl Abelson murine leukemia viral oncogene homolog 1 (ABL1); neuropilin 1 (NRP1) BriefCommunication Pages: 803 - 803
Solute carrier family 2 facilitated glucose transporter member 1 (SLC2A1; GLUT1) BriefCommunication Pages: 806 - 806
In vivo infection system to predict epidemic variants of mosquito-borne RNA viruses BriefCommunication Pages: 807 - 807
Chemically defined medium for generation of human cardiomyocytes from induced pluripotent stem (iPS) cells BriefCommunication Pages: 809 - 809
Depletion of host hematopoietic stem cells (HSCs) in utero improves engraftment after liver mononuclear cell transplant in fetuses BriefCommunication Pages: 810 - 810
Influenza A virus hemagglutinin stem fragment to induce broadly neutralizing antibodies BriefCommunication Pages: 811 - 811
Luciferase-based indicators of drugs (LUCIDs) for point-of-care monitoring BriefCommunication Pages: 812 - 812
Ultra-small rigid platform (USRP) contrast agents for MRI detection of non–small cell lung cancer (NSCLC) BriefCommunication Pages: 813 - 813
Monitoring microRNA-1202 (miR-1202) expression to predict antidepressant treatment response BriefCommunication Pages: 814 - 814